Cytokinetics EVP R&D Malik Fady Ibraham disposes of 3,500 common shares for $282,065 - CYTK News | RalliesCytokinetics EVP R&D Malik Fady Ibraham disposes of 3,500 common shares for $282,065
C
CYTK• Insider exercise and sale
- Cytokinetics EVP, Research & Development Malik Fady Ibraham exercised 3,500 shares of common stock options at USD 7.8 on July 21, 2026.
- He sold 3,500 common shares the same day at USD 80.59.
- He reported 153,902 common shares owned following the transactions.
- He reported 33,886 non-qualified stock options remaining after the exercise.
CYCU
•
